Prostate Health Market Growth Analysis, Trending Strategies and Key Players 2032 | Abbott Laboratories, Amgen Inc., Astellas Pharma Inc

The Global Prostate Health Market Size is to Grow from USD 32.7 Billion in 2023 to USD 78.04 Billion by 2032, at a Compound Annual Growth Rate (CAGR) of 9.13% during the projected period.

Cancer that starts in the prostate is known as prostate cancer. The prostate, a small gland in males similar to a walnut, generates seminal fluid that nourishes and carries sperm. Due to its impact on a larger percentage of older men, it poses a significant health risk, particularly in developed nations. Cancer patients can gain from exercise in various ways, such as enhanced quality of life and greater capacity to perform everyday activities. Prostate cancer is a gradually advancing disease that first predominantly impacts the prostate gland but may eventually metastasize to other areas of the body, particularly the bones and lymph nodes. Numerous prostate tumors are symptomless, develop gradually, and are confined to the prostate gland. Some may spread rapidly and inflict significant harm, while others would require treatment. Several factors, such as smoking, obesity levels, lifestyle habits, and the development of advanced methods for diagnosing and treating prostate cancer, contribute to the increase in revenue in this market. Advancements in imaging technologies, robotic surgery assistance, and precision medicine, along with other treatment methods, are propelling market expansion.

Updated Version of Sample Report Included:
https://www.marketdigits.com/request/sample/4913

Prostate Health Market Growth Drivers:

The rising prevalence of benign prostatic hyperplasia, rising overweight, rise in prevalence of cancer, an increased number of prostatitis are all driving industry growth. Obesity and BPH are strongly intertwined. As per the WHO, In 2020, 39 million children under the age of five were overweight and obese. In 2016, nearly 340 million children and youth aged 5 to 19 were overweight or obese. Obesity causes various factors, including increased sympathetic nerve activity, abdominal pressure, an inflammatory reaction, and oxidative stress, all of which enhance BPH development. In the Asia Pacific, Australia has the highest prevalence of cancer. This is augmenting the market for prostate health market growth.

Major Players in Prostate Health Markets are:
Abbott Laboratories, Amgen Inc., Astellas Pharma Inc., AstraZeneca PLC, Bayer AG, Bristol-Myers Squibb Co., Eli Lilly and Company, Endo Pharmaceuticals Inc., Ferring Pharmaceuticals Inc., GlaxoSmithKline PLC, Johnson & Johnson, Merck & Co., Inc., Pfizer Inc., and Siemens Healthcare AG.

Industry News:

In April 2024, Astellas Pharma Inc. received approval from the European Commission to extend XTANDI (enzalutamide) use. The decision permits its use alone or with androgen deprivation therapy in adult men with high-risk biochemical recurrent non-metastatic hormone-sensitive prostate cancer who are not suitable for salvage radiotherapy.

In February 2023, Pfizer announced positive results from the Phase 3 TALAPRO-2 trial evaluating TALZENNA (talazoparib) combined with XTANDI (enzalutamide) in men with metastatic castration-resistant prostate cancer (mCRPC). The combination significantly reduced the risk of disease progression or death by 37% compared to placebo plus XTANDI. These findings suggest that adding TALZENNA to XTANDI may offer a promising treatment option for patients with mCRPC, addressing an unmet need in advanced prostate cancer therapy.

"Connect with our team of research specialists and unlock the optimal solution for driving your business growth"

Global Prostate Health Market Segmentation:

Global Prostate Health Market, By Disease Indication
Benign Prostate Hyperplasia (BPH)
Prostate Cancer
Alpha Blockers
Prostatitis
Others

Global Prostate Health Market, By Treatment
Radiation Therapy
Hormones ADT
AR Directed Therapies
Cytotoxic Agents and Therapeutics
Others

Global Prostate Health Market, By Distribution Channel
E-Commerce Stores
Pharmacies
Others

Know more about this report:
https://www.marketdigits.com/prostate-health-market-1725973555

The following areas and countries are covered in the worldwide Prostate Health Market file:

North America (US, Canada, Mexico)
Europe (Germany, France, UK, Russia, Italy)
Asia Pacific (China, Japan, South Korea, India, Southeast Asia)
South America (Brazil, Argentina, Colombia, etc.)
Middle East and Africa (Saudi Arabia, UAE), Egypt, Nigeria, and South Korea)

North America is expected to hold the largest share of the global prostate health market over the forecast period. Due to advancements in medical care and the rising prevalence of benign prostatic hyperplasia (BPH). Strong healthcare infrastructure, research funding, fair remuneration regulations, and an increase in new product launches have all contributed to the expansion of the prostate health industry in the area. The growing target population, the high incidence of prostatitis, prostate cancer, and benign prostatic hyperplasia (BPH), as well as the dominance of medical device manufacturers, are all factors driving the North American market's growth.

Detailed industry forecast-Brief Introduction to the research report:

Additional information on company participants
Customized reports and analyst assistance are available upon request.
Recent market developments and potential future growth opportunities
Personalized regional/country reports upon request
New data sources are being integrated.
Increased focus on data privacy and security
Increased collaboration and co-creation

Key Features of the Prostate Health Market Report: -

Analyze competitive developments such as expansions, deployments, new product launches, and market acquisitions.

Examine the market opportunities for stakeholders by identifying higher growth sections.

To study and analyze the global Prostate Health Market industry status and forecast including key regions.

An in-depth analysis of key product segments and application spectrum, providing strategic recommendations to incumbents and new entrants to give them a competitive advantage over others.

It provides a comprehensive analysis of key regions of the industry as well as a SWOT analysis and Porter's Five Forces analysis to provide a deeper understanding of the market.

It helps you make strategic business decisions and investment plans.
Finally, Prostate Health Market is a valuable source of guidance for individuals and companies.

Discover More: Visit Our Website for Additional Reports!

https://www.globenewswire.com/news-release/2024/02/22/2833893/0/en/Underwater-Warfare-Market-projected-to-reach-USD-6-8-Billion-by-2030-growing-at-a-CAGR-of-9-0-during-the-forecast-period-of-2023-2030-pronounced-by-MarketDigits-in-its-recent-study.html

https://www.globenewswire.com/news-release/2024/02/23/2834265/0/en/Single-Cell-Omics-Market-projected-to-reach-USD-12-7-Billion-by-2030-growing-at-a-CAGR-of-20-8-during-the-forecast-period-of-2023-2030-pronounced-by-MarketDigits-in-its-recent-stud.html

https://www.globenewswire.com/news-release/2024/02/23/2834296/0/en/Sequencing-Consumables-Market-projected-to-reach-USD-30-8-Billion-by-2030-growing-at-a-CAGR-of-23-during-the-forecast-period-of-2023-2030-professed-by-MarketDigits-in-its-recent-st.html

https://www.globenewswire.com/news-release/2024/02/23/2834511/0/en/CF-CFRP-Market-Size-Share-Envisaged-To-Reach-USD-79-45-Billion-by-2030-Global-Report-by-MarketDigits.html

https://www.globenewswire.com/news-release/2024/02/23/2834520/0/en/PFAS-Testing-Market-projected-to-reach-USD-693-2-Million-by-2030-growing-at-a-CAGR-of-15-3-during-the-forecast-period-of-2023-2030-says-MarketDigits-in-its-latest-study.html

About Us

Founded in 2015, MarketDigits Consulting & Advisory Pvt Ltd is a leading business research and consulting firm. Our mission is to empower clients by identifying emerging opportunities and driving revenue growth across industries. We specialize in providing comprehensive market insights, advanced technology solutions, and actionable strategies that support operational and strategic decision-making.

With a focus on the full value chain, our expert team delivers high-quality syndicate research reports, proprietary databases, and consulting services to help clients navigate today's competitive and dynamic business environment. At MarketDigits, we use advanced analysis to uncover profitable opportunities, enabling businesses to make smart decisions and achieve sustainable success.

Contact Us:

+1 510-730-3200 | +1 276-206-2055

sales@marketdigits.com

1248 CarMia Way Richmond

VA 23235, United States

This release was published on openPR.